ResearcherOsaka National HospitalActive in the last 2 years
Motohiro Hirao
Matched on ORCID iD 0000-0002-6509-6416; OpenAlex author ID A5082376679. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 20
2013: 1 paper · 2014: none · 2015: none · 2016: 2 papers · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper
Papers 7
- The relationship between observation interval and prognosis in pancreatic cancer concomitant with intraductal papillary mucinous neoplasia. Co-author DOI 10.1016/j.pan.2023.11.005↗
- [A Case of Conversion Surgery after Long-Term Chemotherapy for Pancreatic Cancer with Peritoneal Metastasis]. Last author PMID 36759995↗
- [A Case of Long-Term Survival after Total Pancreatectomy for Recurrent Pancreatic Cancer in the Remnant Pancreas after Pancreatoduodenectomy]. Co-author PMID 30914550↗
- Successful conversion surgery for unresectable pancreatic cancer with peritoneal metastases after neoadjuvant albumin-bound paclitaxel and gemcitabine chemothe… Co-author DOI 10.1007/s13691-017-0311-0↗
- Prognostic impact of preoperative NLR and CA19-9 in pancreatic cancer. Co-author DOI 10.1016/j.pan.2015.10.006↗
- [Endoscopic Stent Placement to Alleviate Afferent Loop Syndrome Following Recurrence of Pancreatic Cancer]. Co-author PMID 28133265↗
- [Bypass surgery or stent placement for biliary obstruction in patients with unresectable pancreatic cancer]. Co-author PMID 24393895↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shoji Nakamori · 3 shared papers, 2016–2019 · strength 0.21
- Paper [A Case of Long-Term Survival after Total Pancreatectomy for Recurrent Pancreatic Cancer in the Remnant Pancreas after … PMID 30914550↗
- Paper Successful conversion surgery for unresectable pancreatic cancer with peritoneal metastases after neoadjuvant albumin-b… DOI 10.1007/s13691-017-0311-0↗
- Paper Prognostic impact of preoperative NLR and CA19-9 in pancreatic cancer. DOI 10.1016/j.pan.2015.10.006↗
- Atsushi Miyamoto · 3 shared papers, 2016–2019 · strength 0.21
- Paper [A Case of Long-Term Survival after Total Pancreatectomy for Recurrent Pancreatic Cancer in the Remnant Pancreas after … PMID 30914550↗
- Paper Successful conversion surgery for unresectable pancreatic cancer with peritoneal metastases after neoadjuvant albumin-b… DOI 10.1007/s13691-017-0311-0↗
- Paper Prognostic impact of preoperative NLR and CA19-9 in pancreatic cancer. DOI 10.1016/j.pan.2015.10.006↗
- Mitsugu Sekimoto · 3 shared papers, 2016–2019 · strength 0.21
- Paper [A Case of Long-Term Survival after Total Pancreatectomy for Recurrent Pancreatic Cancer in the Remnant Pancreas after … PMID 30914550↗
- Paper Successful conversion surgery for unresectable pancreatic cancer with peritoneal metastases after neoadjuvant albumin-b… DOI 10.1007/s13691-017-0311-0↗
- Paper Prognostic impact of preoperative NLR and CA19-9 in pancreatic cancer. DOI 10.1016/j.pan.2015.10.006↗
- Tadashi Kegasawa · 1 shared paper, 2024 · strength 0.16
- Junya Okabe · 1 shared paper, 2024 · strength 0.16
- Katsuhiko Sato · 1 shared paper, 2024 · strength 0.16
- Kenji Ikezawa · 1 shared paper, 2024 · strength 0.16
- Kengo Matsumoto · 1 shared paper, 2024 · strength 0.16
- Teppei Yoshioka · 1 shared paper, 2024 · strength 0.16
- Tetsuo Takehara · 1 shared paper, 2024 · strength 0.16
- Reishi Toshiyama · 1 shared paper, 2023 · strength 0.16
- Michihiro Enoki · 1 shared paper, 2023 · strength 0.16
- Kunihito Gotoh · 1 shared paper, 2023 · strength 0.16
- Masahiro Murakami · 2 shared papers, 2013–2016 · strength 0.08
- Junichi Hasegawa · 2 shared papers, 2013–2016 · strength 0.08
- Yuta Kobayashi · 1 shared paper, 2018 · strength 0.07
- Chikato Koga · 1 shared paper, 2016 · strength 0.05
- Tadafumi Asaoka · 1 shared paper, 2016 · strength 0.05
- Masanori Tsujie · 1 shared paper, 2016 · strength 0.05
- Riichiro Nezu · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.